Nordic was established in 1964 with a focus on immunology and holds over 1.700 specific antisera to human, mouse, monkey and rat immunoglobulin classes and their subclasses. Of interest may also be a wide range of polyclonal antisera to other serum proteins of different animal species and a unique series of polyclonal antisera against enzymes. Practically all antibodies are also offered as fluorescent and horse-radish peroxidase conjugates as well as biotin conjugates for labels of the customers own choice.
MUbio was created in 2000 and was spun out of Maastricht University in the Netherlands which gave rise to its name. Since its inception MUbio has developed 500 of its own products, many of which are exclusive clones available only to MUbio.
Nordic-MUbio has the ambition to become an important niche player in the following market segments:
- Monoclonal antibodies for Research Use Only
- Discovery and validation of new targets (biomarkers) with applications in diagnostic assays
- Ready-to-use tested flow cytometry antibodies with FIX&PERM®.
Our products are all highly validated; over 80% of our antibodies are tested in immunohistochemistry on frozen tissues, almost 70% of our products have been testd in Flow Cytometry and over 50% are tested in Western Blot. Other applications include IHC on paraffin embedded tissues (40%), immunoprecipitation (15%) and immunofluorescence (6%).
Our antibodies target the following proteins:
|Antibodies directed to||Interest fields|
|Cell adhesion molecules||Cancer|
|Cell cycle markers||Cardiovascular|
|CD markers||Cell adhesion|
|Cytoskeletal proteins||Cell differentiation|
|Extracellular matrix proteins||Cell proliferation|
|Filamentous phage proteins||Cell signaling|
|Nuclear proteins||Stem cell research|
Also, cross species reactivity is an important asset of Nordic-MUbio´s antibodies. In particular, Nordic-Mubio is offering antibodies to be used in the zebrafish model of the pharmaceutical R&D.